TLR4 and coronary artery disorder: Our previous research indicated that RFX1 contributed to the overexpression of TLR4 and the activation of CD14+ monocytes in CAD patients by altering DNA methylation and histone modifications in the TLR4 promoter region (Du et al., 2019).